Active Pharmaceutical Ingredients: Global Markets

Active Pharmaceutical Ingredients: Global Markets

Report Scope

This goal of this report is to impart in-depth knowledge of the global market for active pharmaceutical ingredients (APIs), in terms of both qualitative and quantitative data, to help readers assess the market landscape, develop business/growth strategies, and analyze their market position. BCC Research estimates market size for 2023 (the base year) and forecasts values for 2024 by the end of 2029. It is important to note that market size reflects the demand for APIs within a region or country rather than the API industry itself.

In this report, the API market is analyzed by manufacturer type, production method, molecule type, region and country. Industry growth trends, drivers, restraints and opportunities in the API market are also discussed in detail. The scope of the study is global.

Report Includes

64 data tables and 38 additional tables

An analysis of the global markets for active pharmaceutical ingredients (APIs)

Analyses of global market trends, with market revenue data from 2022 to 2023, estimates for 2024, forecast for 2025, and projected CAGRs through 2029

Estimates of the size and revenue prospects of the global market, along with a market share analysis by origin, drug molecular entity type, manufacturer type, end use and region

Facts and figures pertaining to the market dynamics, technical advances, API sources, production methods, route of synthesis, regulations, and the impact of macroeconomic variables

A Porter’s Five Forces model, and global supply chain and PESTLE analyses

Patent activity featuring issues like patent expiry and its impact on the pharmaceutical market, and details of changes in pharmaceutical drug development

Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies

Analysis of the industry structure, including companies’ market shares, strategic alliances, M&A activity and a venture funding outlook

Company profiles of major players within the industry, including Pfizer Inc., Thermo Fisher Scientific Inc., EuroAPI, Lonza, Siegfried Holding AG, and Divi’s Laboratories Ltd.

Companies Mentioned

Aurobindo Pharma
Divi’s Laboratories Ltd.
Euroapi
Evonik Industries Ag
Lonza
Pfizer Inc.
Siegfried Holding Ag
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific Inc.
Wuxi Apptec